Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (AU2016362282) Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use

Office : Australia
Application Number: 2016362282 Application Date: 30.11.2016
Publication Number: 2016362282 Publication Date: 08.06.2017
Publication Kind : A1
Prior PCT appl.: Application Number:US2016064285 ; Publication Number: Click to see the data
IPC:
C12Q 1/68
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1
Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
68
involving nucleic acids
CPC:
A61K 48/005
A61K 31/7105
A61K 47/26
A61K 47/549
A61K 48/0016
C12N 15/102
C12N 15/113
C12N 15/80
C12N 15/8509
C12N 2310/20
C12Q 1/68
Applicants: Duke University
Inventors:
Agents: Griffith Hack
Priority Data: 62/260,712 30.11.2015 US
62/330,336 02.05.2016 US
Title: (EN) Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use
Abstract: front page image
(EN) Disclosed herein are therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use.
Also published as:
CA3001623IN201837014278KR1020180081618EP3384055CN108779466US20180353615
BR112018011133EA201891317WO/2017/095967